Randomized, Age-stratified, Double Blind, Controlled Phase 3 Study Comparing a Vero Cell-derived Trivalent Seasonal Influenza Vaccine Made by the Modified Manufacturing Process With Vaccine Made by the Current Manufacturing Process and a Licensed Trivalent Influenza Vaccine in Healthy Adults Aged 18 Years and Older
Phase of Trial: Phase III
Latest Information Update: 08 Jun 2015
Price : $35 *
At a glance
- Drugs Influenza virus vaccines (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; Pharmacodynamics; Registrational
- Sponsors Baxter Healthcare Corporation
- 17 Apr 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 25 Mar 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 30 Jan 2013 New trial record